Search research articles
Contact Us
Filters
Showing results (31-40 of 135) with videos related to
Page
of 14
Sort By:
BJU International
|
July 25, 2013
Primary treatment of the prostate improves local palliation in men who ultimately develop castrate-resistant prostate cancer
Andy C M Won, Howard Gurney, Gavin Marx, et al.
Asia-Pacific Journal of Clinical Oncology
|
March 3, 2022
Clinical evidence and insights supporting the use of avelumab first-line maintenance treatment in patients with advanced urothelial carcinoma in the Asia-Pacific region
Masatoshi Eto, Jae-Lyun Lee, Yen-Hwa Chang, et al.
Journal of Mass Spectrometry : JMS
|
July 30, 2020
Evaluating bioanalytical capabilities of paper spray ionization for abiraterone drug quantification in patient plasma
Atul Bhatnagar, Matthew J McKay, Malmaruha Arasaratnam, et al.
Neuropsychological Rehabilitation
|
March 4, 2026
Changes in perceived cognitive functioning following a codesigned online group cognitive rehabilitation for prostate cancer survivors on androgen deprivation therapy: Series of single-case experimental designs
Lorna Pembroke, Kerry A Sherman, Haryana M Dhillon, et al.
Cancer Chemotherapy and Pharmacology
|
May 14, 2019
Inter- and intra-patient variability in pharmacokinetics of abiraterone acetate in metastatic prostate cancer
Malmaruha Arasaratnam, Megan Crumbaker, Atul Bhatnagar, et al.
Seminars in Oncology Nursing
|
July 25, 2024
Online Group Cognitive Rehabilitation Program for Prostate Cancer Survivors: Development Using Codesign and the Theoretical Domains Framework
Lorna Pembroke, Kerry A Sherman, Haryana M Dhillon, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
July 22, 2024
What is the nature and impact of cognitive difficulties following hormonal treatments for prostate cancer?: An interpretative phenomenological analysis
Lorna Pembroke, Kerry A Sherman, Haryana M Dhillon, et al.
The Medical Journal of Australia
|
January 28, 2023
Dual-energy x-ray absorptiometry assessment of bone health in Australian men with prostate cancer commencing androgen deprivation therapy
Mariya F Hamid, Amy Hayden, Tania Moujaber, et al.
Cancer Treatment Reviews
|
September 14, 2010
Moving towards dose individualization of tyrosine kinase inhibitors
Heinz-Josef Klümpen, Caroline F Samer, Ron H J Mathijssen, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
March 14, 2018
Quantitation of the anticancer drug abiraterone and its metabolite Δ(4)-abiraterone in human plasma using high-resolution mass spectrometry
Atul Bhatnagar, Matthew J McKay, Megan Crumbaker, et al.
Page
of 14
Search research articles
Search
Showing results (31-40 of 135) with videos related to
Sort By:
Page
of 14
BJU International
|
July 25, 2013
Primary treatment of the prostate improves local palliation in men who ultimately develop castrate-resistant prostate cancer
Andy C M Won, Howard Gurney, Gavin Marx, et al.
Asia-Pacific Journal of Clinical Oncology
|
March 3, 2022
Clinical evidence and insights supporting the use of avelumab first-line maintenance treatment in patients with advanced urothelial carcinoma in the Asia-Pacific region
Masatoshi Eto, Jae-Lyun Lee, Yen-Hwa Chang, et al.
Journal of Mass Spectrometry : JMS
|
July 30, 2020
Evaluating bioanalytical capabilities of paper spray ionization for abiraterone drug quantification in patient plasma
Atul Bhatnagar, Matthew J McKay, Malmaruha Arasaratnam, et al.
Neuropsychological Rehabilitation
|
March 4, 2026
Changes in perceived cognitive functioning following a codesigned online group cognitive rehabilitation for prostate cancer survivors on androgen deprivation therapy: Series of single-case experimental designs
Lorna Pembroke, Kerry A Sherman, Haryana M Dhillon, et al.
Cancer Chemotherapy and Pharmacology
|
May 14, 2019
Inter- and intra-patient variability in pharmacokinetics of abiraterone acetate in metastatic prostate cancer
Malmaruha Arasaratnam, Megan Crumbaker, Atul Bhatnagar, et al.
Seminars in Oncology Nursing
|
July 25, 2024
Online Group Cognitive Rehabilitation Program for Prostate Cancer Survivors: Development Using Codesign and the Theoretical Domains Framework
Lorna Pembroke, Kerry A Sherman, Haryana M Dhillon, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
July 22, 2024
What is the nature and impact of cognitive difficulties following hormonal treatments for prostate cancer?: An interpretative phenomenological analysis
Lorna Pembroke, Kerry A Sherman, Haryana M Dhillon, et al.
The Medical Journal of Australia
|
January 28, 2023
Dual-energy x-ray absorptiometry assessment of bone health in Australian men with prostate cancer commencing androgen deprivation therapy
Mariya F Hamid, Amy Hayden, Tania Moujaber, et al.
Cancer Treatment Reviews
|
September 14, 2010
Moving towards dose individualization of tyrosine kinase inhibitors
Heinz-Josef Klümpen, Caroline F Samer, Ron H J Mathijssen, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
March 14, 2018
Quantitation of the anticancer drug abiraterone and its metabolite Δ(4)-abiraterone in human plasma using high-resolution mass spectrometry
Atul Bhatnagar, Matthew J McKay, Megan Crumbaker, et al.
Page
of 14